Leveraging the Gut to Treat Metabolic Disease

被引:56
作者
Gimeno, Ruth E. [1 ]
Briere, Daniel A. [1 ]
Seeley, Randy J. [2 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46225 USA
[2] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
关键词
GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED RECEPTOR; Y GASTRIC BYPASS; DEPENDENT INSULINOTROPIC POLYPEPTIDE; TYPE-2; DIABETES-MELLITUS; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; VERTICAL SLEEVE GASTRECTOMY; BILE-ACID RECEPTOR; REDUCE FOOD-INTAKE; WEIGHT-LOSS;
D O I
10.1016/j.cmet.2020.02.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
25 years ago, the suture of treating obes and diabetes focused on end organs known to be involved in energy balance and glucose regulation, including the brain, muscle, adipose tissue, and pancreas. Today. the most effective therapies are focused around the gut. This includes surgical options, such as vertical sleeve gastrectomy and Roux-en-Y gastric bypass, that can produce sustained weight loss and diabetes remission but also extends to pharmacological treatments that simulate or amplify various signals that come from the gut. The purpose of this Review is to discuss the wealth of approaches currently under development that seek to further leverage the gut as a source of novel therapeutic opportunities with the hope that we can achieve the effects of surgical interventions with less invasive and more scalable solutions.
引用
收藏
页码:679 / 698
页数:20
相关论文
共 247 条
  • [1] Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
    Aaboe, K.
    Knop, F. K.
    Vilsboll, T.
    Deacon, C. F.
    Holst, J. J.
    Madsbad, S.
    Krarup, T.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (04) : 323 - 333
  • [2] KATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes
    Aaboe, Kasper
    Knop, Filip Krag
    Vilsboll, Tina
    Volund, Aage
    Simonsen, Ulf
    Deacon, Carolyn Fiona
    Madsbad, Sten
    Holst, Jens Juul
    Krarup, Thure
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 603 - 608
  • [3] Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus
    Addy, Carol
    Tatosian, Daniel
    Glasgow, Xiaoli S.
    Gendrano, Isaias N., III
    Kauh, Eunkyung
    Martucci, Ashley
    Johnson-Levonas, Amy O.
    Selverian, Diana
    Matthews, Catherine Z.
    Gutierrez, Marie
    Wagner, John A.
    Stoch, S. Aubrey
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (03) : 516 - 530
  • [4] Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
    Adriaenssens, Alice E.
    Biggs, Emma K.
    Darwish, Tamana
    Tadross, John
    Sukthankar, Tanmay
    Girish, Milind
    Polex-Wolf, Joseph
    Lam, Brain Y.
    Zvetkova, Ilona
    Pan, Warren
    Chiarugi, Davide
    Yeo, Giles S. H.
    Blouet, Clemence
    Gribble, Fiona M.
    Reimann, Frank
    [J]. CELL METABOLISM, 2019, 30 (05) : 987 - +
  • [5] PEPTIDE YY KINETICS AND EFFECTS ON BLOOD-PRESSURE AND CIRCULATING PANCREATIC AND GASTROINTESTINAL HORMONES AND METABOLITES IN MAN
    ADRIAN, TE
    SAGOR, GR
    SAVAGE, AP
    BACARESEHAMILTON, AJ
    HALL, GM
    BLOOM, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) : 803 - 807
  • [6] HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY
    ADRIAN, TE
    FERRI, GL
    BACARESEHAMILTON, AJ
    FUESSL, HS
    POLAK, JM
    BLOOM, SR
    [J]. GASTROENTEROLOGY, 1985, 89 (05) : 1070 - 1077
  • [7] Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance
    Ahlqvist, Emma
    Osmark, Peter
    Kuulasmaa, Tiina
    Pilgaard, Kasper
    Omar, Bilal
    Brons, Charlotte
    Kotova, Olga
    Zetterqvist, Anna V.
    Stancakova, Alena
    Jonsson, Anna
    Hansson, Ola
    Kuusisto, Johanna
    Kieffer, Timothy J.
    Tuomi, Tiinamaija
    Isomaa, Bo
    Madsbad, Sten
    Gomez, Maria F.
    Poulsen, Pernille
    Laakso, Markku
    Degerman, Eva
    Pihlajamaki, Jussi
    Wierup, Nils
    Vaag, Allan
    Groop, Leif
    Lyssenko, Valeriya
    [J]. DIABETES, 2013, 62 (06) : 2088 - 2094
  • [8] FOOD INTAKE AND EATING BEHAVIOR AFTER BARIATRIC SURGERY
    Al-Najim, Werd
    Docherty, Neil G.
    le Roux, Carel W.
    [J]. PHYSIOLOGICAL REVIEWS, 2018, 98 (03) : 1113 - 1141
  • [9] Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
    Albaugh, Vance L.
    Banan, Babak
    Antoun, Joseph
    Xiong, Yanhua
    Guo, Yan
    Ping, Jie
    Alikhan, Muhammed
    Clements, Blake Austin
    Abumrad, Naji N.
    Flynn, Charles Robb
    [J]. GASTROENTEROLOGY, 2019, 156 (04) : 1041 - +
  • [10] Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma
    Albrechtsen, Nicolai J. Wewer
    Hornburg, Daniel
    Albrechtsen, Reidar
    Svendsen, Berit
    Torang, Signe
    Jepsen, Sara L.
    Kuhre, Rune E.
    Hansen, Marie
    Janus, Charlotte
    Floyd, Andrea
    Lund, Asger
    Vilsboll, Tina
    Knop, Filip K.
    Vestergaard, Henrik
    Deacon, Carolyn F.
    Meissner, Felix
    Mann, Matthias
    Holst, Jens J.
    Hartmann, Bolette
    [J]. EBIOMEDICINE, 2016, 7 : 112 - 120